MedTrace Logo

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

NCT01522573 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-02-20

No results posted yet for this study

Summary

The purpose of this registry is to record information and evaluate the impact of Endoscopic Ultrasound (EUS) Guided Endoscopic retrograde cholangiopancreatography (ERCP) on the management of pancreatico-biliary disorders. The registry will evaluate efficacy, safety and technical success of the Endoscopic Ultrasound (EUS)Guided Endoscopic retrograde cholangiopancreatography (ERCP) procedures. The safety and efficacy of various EUS-Guided ERCP procedures have been assessed in a series of studies.

This multi-center registry has been initiated:

* To document the impact of EUS-Guided ERCP procedures on the management of pancreatico-biliary disorders including malignancies.
* To assess the clinical and technical success rates of EUS-Guided ERCPs for diagnostic or therapeutic procedures.

Design is retrospective and prospective registry study.

Procedures that will be captured include:

1. EUS-Coils placement
2. EUS Glue injection
3. EUS-Fiducial placement
4. EUS-Neurolysis
5. EUS-Stent placement
6. EUS-alcohol injection
7. EUS-fluid collection, abscess or cavity drainage
8. EUS guided ductal drainage
9. EUS-guided Ablation
10. EUS-guided anastomosis 11. EUS Guided ERCP for gallbladder, pancreatic duct or biliary duct drainage

Conditions

  • Cholangiocarcinoma
  • Pancreatic Cancer
  • Bile Duct Cancer
  • Biliary Stricture
  • Biliary Obstruction
  • Stent Obstruction
  • Proximal Duct Stricture
  • Distal Duct Stricture
  • Ampullary Cancer
  • Biliary Sphincter Stenosis
  • Impacted Stones
  • Chronic Pancreatitis
  • Peri-ampullary Diverticula
  • Altered Anatomy

Interventions

PROCEDURE

EUS guided ERCP

Endoscopic ultrasound guided (EUS) endoscopic retrograde cholangiopancreatography (ERCP)

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Michel Kahaleh, MD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2018-12-30
Completion
2018-12-30

Countries

  • United States
  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01522573 on ClinicalTrials.gov